Dianthus Therapeutics's total assets for Q1 2026 were $1.25B, an increase of 134.85% from the previous quarter. DNTH total liabilities were $45.57M for the fiscal quarter, a 21.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.